Intrinsiqs

Is Phathom Pharmaceuticals, Inc. overvalued?

Phathom Pharmaceuticals, Inc. (PHAT) — key valuation metrics and fundamentals.

No verdict
Price
$11.00
Fair value
Current P/E
Normal P/E
Market cap
$886.6M
Dividend yield
Return on equity
Sector
Healthcare

See the full interactive analysis →

Fair value compares PHAT's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 30 Jun 2026.